Clin2
NCT05723679Possibly a fitRecruiting

Breathing-targeted program to improve function in HFpEF

Heart Failure With Preserved Ejection FractionObesity

Part of Hormones & metabolism clinical trials.

This trial studies a breathing-focused treatment to help people with HFpEF (a type of heart failure) feel and function better. It may help improve daily activity by addressing breathing limits that commonly come with this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
78 people
Ages
55 years to 90 years
Study type
Interventional

Who can take part

  • You have signs and symptoms of heart failure
  • Your heart pumping test shows ejection fraction above 50%
  • You have evidence of “diastolic dysfunction,” such as high NT-proBNP (over 300) or a recent heart failure hospitalization
  • You are age 55 or older (or you are a healthy volunteer, if that applies to you)
  • Your body mass index (BMI) is 50 or lower
  • You do not have conditions that strongly affect breathing or mobility (like severe COPD or limited walking)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05464238Not yet recruiting
Training program for people with HFpEF and PH

This study tests a training approach for adults who have breathlessness from HFpEF (heart pumping that is preserved) together with PH (pulmonary hypertension). It aims to see if structured training can be done safely while your usual heart medicines stay stable.

Heidelberg
NCT04913805Recruiting· Phase 2
Study for HFpEF using heart pressure and energy signals

This Phase 2 study tests how matching heart “filling pressure” and heart muscle “energy use” may improve understanding or treatment of HFpEF, a type of heart failure with preserved pumping strength. You may be asked to have heart scans/tests and follow a study plan if your symptoms and test results fit.

Philadelphia, Pennsylvania
NCT07123779Recruiting· Phase 1/Phase 2
Study of HS235 in obese patients with pulmonary hypertension and heart failure

This trial tests an investigational drug called HS235 in people who have both obesity (BMI 30-50) and a specific type of heart failure with preserved pumping function, along with high blood pressure in the lungs. The goal is to see if the drug can improve symptoms and quality of life.

Greenville, South Carolina
NCT05582044Recruiting
Exercise using leg suction for heart failure with preserved function

This study tests whether a specific lower-body exercise method using negative pressure (leg suction) can improve symptoms and heart-related function in people with heart failure with preserved ejection fraction (HFpEF). You may also be offered screening if you are a healthy person, to compare results.

Kelowna, British Columbia
NCT07413198Recruiting
Combined home and clinic exercise coaching for heart failure

This trial tests a program that combines home-based and clinic-based exercise coaching to help people with heart failure get more active. It aims to improve health and quality of life.

Winston-Salem, North Carolina
NCT07223242Recruiting· Phase 2/Phase 3
Tailored exercise training for heart failure with preserved pumping strength

This trial tests a personalized exercise program to help people with a type of heart failure called HFpEF. You may qualify if your heart still pumps well but you have trouble being active, and you are willing to use a phone app and exercise regularly.

Dallas, Texas

Hear when a new Heart Failure With Preserved Ejection Fraction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.